Rekah Pharmaceutical Industry Ltd (REKA) — Net Asset Quality Index
Rekah Pharmaceutical Industry Ltd (REKA) has a Net Asset Quality Index of 33.3% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ILA421.48 Million minus total liabilities of ILA281.29 Million yields net assets of ILA140.18 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Rekah Pharmaceutical Industry Ltd (REKA) total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Rekah Pharmaceutical Industry Ltd Net Asset Quality Index Over Time (2004–2025)
This chart shows how Rekah Pharmaceutical Industry Ltd's Net Asset Quality Index has evolved across 22 annual periods from 2004 to 2025. As of June 2026, the index stands at 33.3%, representing net assets of ILA140.18 Million against total assets of ILA421.48 Million ILA. For live market cap and overall valuation, see REKA market cap.
Annual Net Asset Quality Index for Rekah Pharmaceutical Industry Ltd (2004–2025)
The table below presents the year-by-year Net Asset Quality Index for Rekah Pharmaceutical Industry Ltd from 2004 to 2025, covering 22 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Rekah Pharmaceutical Industry Ltd (REKA) strategic investment index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (ILA) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 34.0% | ILA144.21 Million | ILA423.68 Million | ILA279.47 Million | ▼ -2.2 pp |
| 2024 | 36.2% | ILA161.98 Million | ILA447.22 Million | ILA285.24 Million | ▲ +4.1 pp |
| 2023 | 32.1% | ILA155.59 Million | ILA484.72 Million | ILA329.14 Million | ▼ -4.0 pp |
| 2022 | 36.1% | ILA162.08 Million | ILA448.42 Million | ILA286.34 Million | ▼ -3.4 pp |
| 2021 | 39.6% | ILA173.06 Million | ILA437.09 Million | ILA264.02 Million | ▲ +0.1 pp |
| 2020 | 39.5% | ILA165.59 Million | ILA419.69 Million | ILA254.10 Million | ▼ -2.8 pp |
| 2019 | 42.3% | ILA155.22 Million | ILA367.11 Million | ILA211.89 Million | ▼ -7.9 pp |
| 2018 | 50.2% | ILA150.66 Million | ILA300.28 Million | ILA149.62 Million | ▲ +1.1 pp |
| 2017 | 49.0% | ILA144.62 Million | ILA294.95 Million | ILA150.33 Million | ▲ +16.2 pp |
| 2016 | 32.8% | ILA105.86 Million | ILA322.72 Million | ILA216.86 Million | ▼ -5.4 pp |
| 2015 | 38.2% | ILA123.66 Million | ILA323.82 Million | ILA200.17 Million | ▲ +13.3 pp |
| 2014 | 24.8% | ILA77.06 Million | ILA310.11 Million | ILA233.05 Million | ▼ -1.4 pp |
| 2013 | 26.2% | ILA79.51 Million | ILA303.16 Million | ILA223.65 Million | ▲ +2.4 pp |
| 2012 | 23.9% | ILA71.17 Million | ILA298.07 Million | ILA226.90 Million | ▲ +1.6 pp |
| 2011 | 22.3% | ILA64.00 Million | ILA286.99 Million | ILA222.98 Million | ▲ +0.2 pp |
| 2010 | 22.1% | ILA63.78 Million | ILA287.97 Million | ILA224.18 Million | ▼ -0.9 pp |
| 2009 | 23.0% | ILA64.15 Million | ILA278.40 Million | ILA214.25 Million | ▲ +2.9 pp |
| 2008 | 20.2% | ILA58.62 Million | ILA290.50 Million | ILA231.87 Million | ▼ -2.1 pp |
| 2007 | 22.3% | ILA67.10 Million | ILA300.96 Million | ILA233.86 Million | ▲ +1.5 pp |
| 2006 | 20.8% | ILA61.54 Million | ILA296.53 Million | ILA234.99 Million | ▼ -1.3 pp |
| 2005 | 22.0% | ILA58.85 Million | ILA267.00 Million | ILA208.15 Million | ▼ -2.1 pp |
| 2004 | 24.2% | ILA48.86 Million | ILA202.04 Million | ILA153.18 Million | — |